Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
API
Manufacturing
India's Aspen Biopharma Labs hit with FDA warning letter
Aspen Biopharma Labs was hit with a warning letter from the FDA outlining multiple issues at its drug ingredients manufacturing facility in India.
Joseph Keenan
Mar 26, 2025 1:09pm
Lilly swells manufacturing outlay to more than $50B since 2020
Feb 26, 2025 9:30am
Eurofins to build $64M biologics production facility in Ontario
Sep 25, 2024 10:43am
Gilead, Yuhan ink $81M HIV API supply pact
Sep 20, 2024 11:20am
EuroAPI telegraphs 2 site sales, hundreds of layoffs
Jun 26, 2024 3:37pm
89bio lines up BiBo Pharma to build $135M commercial API plant
Apr 11, 2024 3:23pm